EUVIMEDObjevte EUVIMED
FallberichtOpen access · CC BY 4.0

Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab

Beatrice Preti iD, Laila Schenkel iD, Matthew Cecchini, Tommaso Romagnoli, Michael Susmoy Sanatani, Karissa French, Patrick Colquhoun, Mark David Vincent

Current Oncology · 2023

DOI: 10.3390/curroncol30100653 ↗

At a glance

Fallbericht in Current Oncology, 2023. Written by Beatrice Preti and 7 co-authors. Institution: Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada. Major MEDLINE topics: Mosaicism, Neoadjuvant Therapy, Colonic Neoplasms. Cited 1 times so far (Crossref); 9 references. The full text is freely available (open access, CC BY 4.0). Funded by: This research received no external funding..

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

We present a fascinating case of a 57-year-old male with a novel mutation in MLH1 (MLH1:c.1288G > T, p.(Glu430*)), who presented with two synchronous colonic tumours, initially deemed unresectable, and experienced a complete pathological response on neoadjuvant pembrolizumab. Extensive genetic testing revealed post-zygotic mosaicism from the novel mutation.

Subjects

MeSH terms (MEDLINE)

MosaicismNeoadjuvant TherapyColonic NeoplasmsHumansMaleMiddle AgedMicrosatellite InstabilityMutationMutL Protein Homolog 1Antibodies, Monoclonal, Humanized

Author keywords

MLH1MSI-Hcolon cancerdMMRimmunotherapy

Substances

MutL Protein Homolog 1MLH1 protein, humanpembrolizumabAntibodies, Monoclonal, Humanized

Authors and institutions

  • Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada.
  • Division of Molecular Diagnostics, Western University, London, ON N6A 3K7, Canada.
  • Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
  • Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
  • Department of Surgery, Western University, London, ON N6A 3K7, Canada.

ORCID profiles: Beatrice Preti, Laila Schenkel

Funding

  • This research received no external funding.

Cite

APA

Preti, B., Schenkel, L., Cecchini, M., Romagnoli, T., Sanatani, M. S., French, K., Colquhoun, P., & Vincent, M. D. (2023). Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. https://doi.org/10.3390/curroncol30100653

Vancouver

Preti B, Schenkel L, Cecchini M, Romagnoli T, Sanatani MS, French K, et al. Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. 2023. doi:10.3390/curroncol30100653

BibTeX
@article{Preti2023,
  author = {Preti, Beatrice and Schenkel, Laila and Cecchini, Matthew and Romagnoli, Tommaso and Sanatani, Michael Susmoy and French, Karissa and Colquhoun, Patrick and Vincent, Mark David},
  title = {Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30100653}
}
Start for free →